Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
October 18, 2023 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that it received a notice (“Notice”) on October 12, 2023 from the Listing...
Lifecore Biomedical Provides Update for Development Portfolio and Timing of Delayed Filings
October 10, 2023 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical Reports Fourth Quarter and Full Fiscal Year 2023 Results
August 31, 2023 07:30 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (Nasdaq: LFCR) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization...
Lifecore Biomedical Sets Fourth Quarter 2023 Earnings Conference Call for August 31, 2023 at 7:30 a.m. CT
August 22, 2023 16:06 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Annual Report
August 22, 2023 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Aug. 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that it received a notice (“Notice”) on August 17, 2023 from the Listing...
Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results
June 01, 2023 07:15 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., June 01, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), reported...
Lifecore Biomedical Enters into $150.0 Million in New Financing, Repays its Outstanding Term Loans and Signs New Supply Agreement to Expand HA Fermentation Capacity with Existing Long-Term Customer
May 22, 2023 16:51 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., May 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company” Nasdaq: LFCR), a fully integrated contract development and manufacturing organization (“CDMO”),...
Lifecore Biomedical Sets Third Quarter 2023 Earnings Conference Call for June 1, 2023 at 7:30 a.m. CT
May 22, 2023 16:49 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., May 22, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Lifecore Biomedical, Inc. Receives Notice from Nasdaq Regarding Delayed Quarterly Report
April 14, 2023 16:35 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., April 14, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) announced today that it received a notice (“Notice”) on April 13, 2023 from the Listing...
Lifecore Biomedical Announces Sale of Curation Foods’ O Olive Oil and Vinegar® Business
April 06, 2023 16:05 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., April 06, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today...